Swetlana Rot

539 total citations
17 papers, 431 citations indexed

About

Swetlana Rot is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Swetlana Rot has authored 17 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Swetlana Rot's work include Cancer, Hypoxia, and Metabolism (8 papers), Sarcoma Diagnosis and Treatment (5 papers) and RNA modifications and cancer (3 papers). Swetlana Rot is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Sarcoma Diagnosis and Treatment (5 papers) and RNA modifications and cancer (3 papers). Swetlana Rot collaborates with scholars based in Germany, France and United Kingdom. Swetlana Rot's co-authors include Matthias Kappler, Matthias Bache, Dirk Vordermark, Henri Wichmann, Helge Täubert, Jacqueline Keßler, Thomas Greither, Antje Güttler, Alexander W. Eckert and Peter Würl and has published in prestigious journals such as International Journal of Molecular Sciences, Radiotherapy and Oncology and BMC Cancer.

In The Last Decade

Swetlana Rot

17 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swetlana Rot Germany 13 273 218 109 83 58 17 431
R. Habets Netherlands 8 357 1.3× 161 0.7× 178 1.6× 56 0.7× 43 0.7× 8 535
Kristina Goetze Germany 7 231 0.8× 240 1.1× 83 0.8× 56 0.7× 29 0.5× 9 417
Ilenia Segatto Italy 14 290 1.1× 198 0.9× 251 2.3× 99 1.2× 29 0.5× 23 536
Shany Koren Switzerland 8 367 1.3× 194 0.9× 320 2.9× 82 1.0× 33 0.6× 9 622
Virginie Clément‐Schatlo Switzerland 5 388 1.4× 308 1.4× 121 1.1× 26 0.3× 75 1.3× 6 545
Chia-Ing Jan Taiwan 7 207 0.8× 101 0.5× 140 1.3× 34 0.4× 52 0.9× 9 383
Tamalee Kramp United States 13 314 1.2× 143 0.7× 148 1.4× 100 1.2× 120 2.1× 25 534
Mette Villingshøj Denmark 11 231 0.8× 86 0.4× 157 1.4× 66 0.8× 106 1.8× 14 405
Mengxian Zhang China 8 355 1.3× 135 0.6× 172 1.6× 46 0.6× 113 1.9× 16 528
Erwin Tomasich Austria 13 336 1.2× 187 0.9× 179 1.6× 120 1.4× 26 0.4× 31 547

Countries citing papers authored by Swetlana Rot

Since Specialization
Citations

This map shows the geographic impact of Swetlana Rot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swetlana Rot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swetlana Rot more than expected).

Fields of papers citing papers by Swetlana Rot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swetlana Rot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swetlana Rot. The network helps show where Swetlana Rot may publish in the future.

Co-authorship network of co-authors of Swetlana Rot

This figure shows the co-authorship network connecting the top 25 collaborators of Swetlana Rot. A scholar is included among the top collaborators of Swetlana Rot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swetlana Rot. Swetlana Rot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kappler, Matthias, Daniel Bethmann, Michael Schwabe, et al.. (2020). Prognostic impact of cytoplasmatic EGFR upregulation in patients with oral squamous cell carcinoma: A pilot study. Molecular and Clinical Oncology. 13(6). 1–1. 5 indexed citations
2.
Eckert, Alexander W., Daniel Bethmann, Johanna Kotrba, et al.. (2019). Investigation of the Prognostic Role of Carbonic Anhydrase 9 (CAIX) of the Cellular mRNA/Protein Level or Soluble CAIX Protein in Patients with Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(2). 375–375. 20 indexed citations
3.
Rot, Swetlana, Helge Täubert, Thomas Greither, et al.. (2019). Prognostic impact of mRNA levels of LGR5 transcript variants in OSCC patients. BMC Cancer. 19(1). 12 indexed citations
4.
Rot, Swetlana, Helge Täubert, Matthias Bache, et al.. (2018). Low HIF-1α and low EGFR mRNA Expression Significantly Associate with Poor Survival in Soft Tissue Sarcoma Patients; the Proteins React Differently. International Journal of Molecular Sciences. 19(12). 3842–3842. 9 indexed citations
5.
Kappler, Matthias, Johanna Kotrba, Matthias Bache, et al.. (2017). P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients. Clinical and Translational Radiation Oncology. 5. 6–11. 26 indexed citations
6.
Greither, Thomas, Swetlana Rot, Jacqueline Keßler, et al.. (2017). CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients. International Journal of Molecular Sciences. 18(12). 2648–2648. 12 indexed citations
7.
Keßler, Jacqueline, Swetlana Rot, Matthias Bache, et al.. (2016). miR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcome. Oncology Letters. 12(6). 5281–5288. 16 indexed citations
8.
Kappler, Matthias, Swetlana Rot, Helge Täubert, et al.. (2016). Normoxic accumulation of HIF1α is associated with glutaminolysis. Clinical Oral Investigations. 21(1). 211–224. 29 indexed citations
9.
Bache, Matthias, Swetlana Rot, Jacqueline Keßler, et al.. (2015). mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma. Oncology Reports. 33(6). 3155–3161. 28 indexed citations
10.
Keßler, Jacqueline, Antje Güttler, Henri Wichmann, et al.. (2015). IDH1R132H mutation causes a less aggressive phenotype and radiosensitizes human malignant glioma cells independent of the oxygenation status. Radiotherapy and Oncology. 116(3). 381–387. 34 indexed citations
11.
Wichmann, Henri, Antje Güttler, Matthias Bache, et al.. (2014). Targeting of EGFR and HER2 with therapeutic antibodies and siRNA. Strahlentherapie und Onkologie. 191(2). 180–191. 21 indexed citations
12.
Rot, Swetlana, Helge Täubert, Matthias Bache, et al.. (2011). A novel splice variant of the stem cell marker LGR5/GPR49 is correlated with the risk of tumor-related death in soft-tissue sarcoma patients. BMC Cancer. 11(1). 429–429. 20 indexed citations
13.
Bache, Matthias, Matthias Kappler, Henri Wichmann, et al.. (2010). Elevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients. BMC Cancer. 10(1). 132–132. 31 indexed citations
14.
Keßler, Jacqueline, Henri Wichmann, Swetlana Rot, et al.. (2010). HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. BMC Cancer. 10(1). 84 indexed citations
15.
Kappler, Matthias, Helge Täubert, Hans-Jürgen Holzhausen, et al.. (2008). Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer. Strahlentherapie und Onkologie. 184(8). 393–399. 39 indexed citations
16.
Kappler, Matthias, Helge Täubert, Hans-Jürgen Holzhausen, et al.. (2008). Immunohistochemical Detection of HIF-1α and CAIX in Advanced Head-and-Neck Cancer. Strahlentherapie und Onkologie. 184(9). 491–491. 25 indexed citations
17.
Kappler, Matthias, Swetlana Rot, Helge Täubert, et al.. (2007). The effects of knockdown of wild-type survivin, survivin-2B or survivin-Δ3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions. Cancer Gene Therapy. 14(12). 994–1001. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Habets Breakdown of academic impact, for papers by Kristina Goetze Breakdown of academic impact, for papers by Ilenia Segatto Breakdown of academic impact, for papers by Shany Koren Breakdown of academic impact, for papers by Virginie Clément‐Schatlo Breakdown of academic impact, for papers by Chia-Ing Jan Breakdown of academic impact, for papers by Tamalee Kramp Breakdown of academic impact, for papers by Mette Villingshøj Breakdown of academic impact, for papers by Mengxian Zhang Breakdown of academic impact, for papers by Erwin Tomasich
Rankless by CCL
2026